FDA Inspection 1166341 — University of Utah IRB

University of Utah IRB — FEI 1718818

The FDA completed an inspection of University of Utah IRB on March 11, 2022 in Salt Lake City, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 11, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Salt Lake City, UT (United States)

Additional Details

IRB